Although coagulatory system disorders are well recognized in patients with acute leukemia, these usually present with either hemorrhagic complications or thrombosis of small vessels. Large vessel thrombosis is a very rare clinical presentation. We present a patient with previously undiagnosed acute myeloid leukemia (M5), who was referred to our hospital with symptoms of acute ischemia of his right lower limb. Occlusion of the right external iliac artery due to a combination of leucostasis and coagulation disorders was noted and successfully treated with urgent leukapheresis, immediate chemotherapy and surgical thromboembolectomy.
Introduction
Although disorders of the coagulation system are well recognized in patients with acute leukemia, these usually present with hemorrhagic complications or thrombosis of small vessels. Large vessel thrombosis is a very rare complication. To our knowledge, there are only nine cases reported in the English literature of acute leukemia presenting as acute lower limb ischemia due to large artery occlusion.
This report describes a patient who was admitted to our hospital under this clinical scenario and was discharged with complete remission without amputation at any level.
Case report
A 57-year-old Caucasian ex-smoker (45 pack-years) with a previous history of chronic obstructive pulmonary disease presented in the emergency department with a 6-hour progressive history of coolness, pallor and pain of the right (Rt) lower limb. He had no history of previous claudication. Clinical examination was unremarkable apart from the findings in the Rt leg. Electrocardiography revealed a regular sinus cardiac rhythm. The Rt leg was cool and pallid with mild sensory loss of the toes, without any motor deficits. The left leg was absolutely normal. Pulses were palpable in all arteries of his left lower limb whereas palpable pulses were found only in the Rt femoral artery. The ankle-brachial pressure index (ABPI) of the left limb was 1.0 (120 mmHg/120 mmHg) and of the right limb was 0.2 (25 mmHg/120 mmHg).
Blood analysis revealed a hematocrit of 33.9% (normal values [NV] 37-47%), platelet count of 50 ϫ 103 (NV: 150-450 ϫ 103), white blood cell count (WBC) of 120 300 cells/l (95% blasts) (NV: 3.8-10.5 ϫ 103 cells/l), INR of 1.37 (NV: 0.85-1.15), aPTT of 43.2 s (NV: 28-40 s), D-dimers Ͼ20 g/ml (NV: 0.0-0.5 g/ml) and fibrinogen of 196 mg/dl (NV: 200-400 mg/dl). In view of these results, an emergent arterial angiography was avoided. Duplex ultrasonography revealed normal flow waveforms up to the level of the popliteal artery, occlusion of the tibioperonial trunk and single-phase flow in the anterior tibial artery. Since the limb was still viable and the coagulation status precluded thombolysis, the patient was admitted to the hematology-oncology department for heparinization and leukapheresis because of possible leucostasis. After this procedure the WBC fell to 50 000 cells/l. Under the provisional morphological diagnosis of acute myeloid leukemia (AML), chemotherapy with AML protocol was initiated (idarubicin 12 mg/m 2 /24 h for 3 days followed by cytarabine 200 mg/m 2 /24 h for 7 days). The immunophenotypic analysis revealed a unique blast population compatible with AML-M5. The next day, the lower limb showed clinical deterioration and now had rest pain. The pulses were no longer palpable in the Rt femoral artery and Doppler signals were no longer audible at the femoral level and distally. This clinical deterioration was obviously due to a new thrombotic event. Without having any blood or blood product transfusions, laboratory results were hematocrit: 32%; platelet count: 53 ϫ 103; INR: 1.35; aPTT: 38.4 s. Despite any risk of possible hemorrhagic complications, an emergency Rt iliofemoral and femoral-popliteal arterial thromboembolectomy was performed under local anesthesia in an effort to salvage the limb. A white-clot plug was removed from the bifurcation of the Rt common iliac artery ( Figure 1A ). An improvement of perfusion of the lower limb was noted immediately after the procedure, with restoration of palpable pulses on the dorsalis pedis and posterior tibial arteries as well as restoration of a normal ABPI. Histological examination of the clot revealed cells with similar characteristics with those of AML-M5 cells ( Figure 1B) .
Complete remission was achieved after the completion of chemotherapy within the next 10 days, without recurrence of further arterial insufficiency, and the patient was discharged after 20 days of hospitalization. At 3 months the patient remains free of symptoms, without any sign of claudication and with complete recovery of initial sensory loss as confirmed after clinical evaluation. Antiplatelet therapy was not prescribed due to an increased risk of hemorrhaging because of a decrease in the platelet count following chemotherapy.
Discussion
Ischemic events in acute leukemia usually involve small vessels of the brain, spleen and lungs. Only nine cases of lower limb ischemia resulting from large arterial occlusion have been presented in the past (Table 1 ). In the first case, the affected artery was the aorta 1 and in the second one the external iliac, the profunda femoral and all tibial arteries. 2 In both cases, leucostasis was the mechanism of ischemia. This is of interest since the most common cause of acute ischemia in acute lymphoblastic leukemia is arterial embolism in patients being actively treated with L-asparaginase or other chemotherapeutic regimens who have associated depression of antithrombin III, plasminogen, fibrinogen and coagulation factor levels. The patients in these case reports had not received any treatment previously and no evidence of coagulopathy was present.
The next three cases involved acute promyelocytic leukemia where the mechanism of ischemia was disseminated intravascular coagulation (DIC). [3] [4] [5] In one case with acute promyelocytic leukemia 6 and in three cases [7] [8] [9] involving AML, the mechanism of lower limb ischemia was leucostasis and subsequent occlusion of an artery by leukemia cells.
The case reported here is interesting in many respects. First, acute ischemia of the lower limb was the presenting symptom of AML in this patient who had no previous history of fever, weight loss, petechia or other hematologic disorders, which is highly unusual. Moreover, the FAB type of leukemia in our patient was M5. According to the FAB classification, M5 is the monocytic variant of AML. There are two subtypes: M5a (monoblastic variant) and M5b (monocytic variant). This type of leukemia develops leukocytosis in 10-30% of patients as well as a relatively high frequency of DIC. The excessive numbers of leucocytes may seriously affect arterial flow by obstructing microchannels or by forming aggregates and white thrombi. Moreover, leukemic blasts may compete for oxygen in the microcirculation, damaging vessel walls. 10 The above, of course, occur in small and medium size arteries, whereas the exact mechanism of clot/emboli development is poorly understood. One may hypothesize that abnormal accumulation of lymphocytes may initially cause the sedimentation of leukemic cells which may then trigger the accumulation of platelets, thus forming a white clot. This clot may form in any part of the arterial tree, though it is usually seen in the periphery (smaller vessels). If the clot is formed in a larger artery then it will of course flow downstream until it is lodged at an artery of smaller diameter or, as usually seen, at a bifurcation site. In general, the embolic material is composed of a mixture of leukemic cells and thrombus, but the amount contained of the two varies among patients.
Treatment of this patient was challenging since, unlike the previously presented cases, he exhibited both leucostasis and coagulation disorders that precluded the use of thrombolytic therapy and interventional radiology. Despite the above-mentioned difficulties, this patient was successfully treated without recurrence of ischemia or amputation at any level. Treatment was rapidly undertaken with urgent leukapheresis and prompt initiation of chemotherapy in this patient in an effort to inhibit any further sedimentation. Despite these therapies, the patient required emergency surgery the following day because of limb deterioration and the presentation of limb-threatening ischemia. Though we cannot draw a definite conclusion from just one case, it is our feeling that leukapheresis and chemotherapy may aid in avoiding thromboembolic recurrence. This is in agreement with Fass et al 6 who attributed the unsuccessful outcome of their patient to delayed initiation of chemotherapy and quoted: 'if remission could have been induced earlier, after initiation of chemotherapy, further propagation of the pathological sedimentation might have been obviated'. To the best of our knowledge there are no articles reporting on the proper approach for treating acute arterial occlusions due to leukemic cells because such embolic occlusions of large arteries are very rare.
Taking into account that thrombolytic therapy is usually not feasible or is unsuccessful and that heparinization is ineffective in these patients, we believe that combined leukapheresis and chemotherapy is the first therapeutic choice unless the limb is immediately threatened. Despite the possibility of coagulation disorders which often cause difficult to control hemorrhage or recurrent thromboembolic events, prompt surgical thromboembolectomy or revascularization should be attempted in such cases presenting with limb-threatening ischemia.
